Adam Diehl

452 total citations
16 papers, 299 citations indexed

About

Adam Diehl is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Adam Diehl has authored 16 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Adam Diehl's work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Cancer Genomics and Diagnostics (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Adam Diehl is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Cancer Genomics and Diagnostics (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Adam Diehl collaborates with scholars based in United States, Chile and Australia. Adam Diehl's co-authors include Elizabeth M. Jaffee, Stuart A. Grossman, Mark Yarchoan, Liangfeng Han, Preethi Korangath, Wei Wen Teo, Soonweng Cho, Manfred Gessler, Nguyen K. Nguyen and Lindsay M. Hannan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Adam Diehl

15 papers receiving 297 citations

Peers

Countries citing papers authored by Adam Diehl

Since Specialization

Citations

This map shows the geographic impact of Adam Diehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Diehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Diehl more than expected).

Fields of papers citing papers by Adam Diehl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Diehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Diehl. The network helps show where Adam Diehl may publish in the future.

Co-authorship network of co-authors of Adam Diehl

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Diehl. A scholar is included among the top collaborators of Adam Diehl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Diehl. Adam Diehl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Association between ex vivo pharmacotyping of patient-derived tumor organoids and personalized therapeutic options for patients with biliary tract cancer. 2025 ·Journal of Clinical Oncology ·Payel Chatterjee, (unknown), Rachele Rosati, (unknown), Robert L. Diaz, (unknown), (unknown), Brady Bernard, Milind Javle, Gentry Teng King, Adam Diehl, William Proctor Harris, Christopher J. Kemp, Carla Grandori	0
2	114P Prospective longitudinal tumor-informed ctDNA in resectable biliary tract cancers 2023 ·Annals of Oncology ·Gentry Teng King, Stacey A. Cohen, E. Gabriela Chiorean, William Proctor Harris, Raymond S. Yeung, (unknown), David B. Zhen, Andrew L. Coveler, Adam Diehl, Rachael A. Safyan, (unknown), (unknown)	4
3	KRASMutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas 2022 ·The Oncologist ·Adam Diehl, Lindsay M. Hannan, David B. Zhen, Andrew L. Coveler, Gentry Teng King, Stacey A. Cohen, (unknown), Veena Shankaran, Kit Man Wong, Steven Green, Natasha Hui Jin Ng, Venu G. Pillarisetty, Jonathan G. Sham, James O. Park, Deepti Reddi, Eric Q. Konnick, Colin C. Pritchard, (unknown), Mary W. Redman, E. Gabriela Chiorean	19
4	HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium 2021 ·Frontiers in Oncology ·Liangfeng Han, Preethi Korangath, Nguyen K. Nguyen, Adam Diehl, Soonweng Cho, Wei Wen Teo, Leslie Cope, Manfred Gessler, Lewis H. Romer, Saraswati Sukumar	13
5	A cancer organogram test as a guide for oncology treatments in SOLID tumors: An analysis of 628 tests in 419 patients. 2021 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), Payel Chatterjee, (unknown), (unknown), Rachele Rosati, (unknown), (unknown), (unknown), (unknown), (unknown), Adam Diehl, Christopher J. Kemp, Barbara A. Goff, Kalyan Banda, William Proctor Harris, Elizabeth M. Swisher, Vijayakrishna K. Gadi, Carla Grandori	2
6	Tumor-informed assessment of circulating tumor DNA and its incorporation into practice for patients with hepatobiliary cancers. 2021 ·Journal of Clinical Oncology ·Pashtoon Murtaza Kasi, (unknown), Farshid Dayyani, Gregory P. Botta, Adam Diehl, Gentry Teng King, Midhun Malla, Maen Abdelrahim, Diana L. Hanna, (unknown), Mohamedtaki Abdulaziz Tejani, (unknown), Paul R. Billings, (unknown), Vasily N. Aushev, Alexey Aleshin	6
7	Prognostic value of KRAS and PI3K pathway mutations for advanced pancreatic ductal adenocarcinoma (PDAC) patients (pts). 2021 ·Journal of Clinical Oncology ·Adam Diehl, Lindsay M. Hannan, E. Gabriela Chiorean	5
8	Trial in progress: A feasibility study of multi-platform profiling using biospecimens from patients with resected biliary tract cancer. 2021 ·Journal of Clinical Oncology ·Adam Diehl, William Proctor Harris, Gentry Teng King	1
9	Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective 2020 ·The Lancet. Gastroenterology & hepatology ·Aisling Barry, Smith Apisarnthanarax, Grainne M. O’Kane, Gonzalo Sapisochín, (unknown), Riad Salem, Sang Min Yoon, Young‐Suk Lim, John Bridgewater, Brian R Davidson, Marta Scorsetti, Luigi Solbiati, Adam Diehl, (unknown), Jonathan G. Sham, David Cavallucci, Zita Galvin, Laura A. Dawson, M. Hawkins	27
10	Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors 2017 ·Oncotarget ·Adam Diehl, Mark Yarchoan, (unknown), Elizabeth M. Jaffee, Stuart A. Grossman	175
11	Relationship between lymphopenia and objective response rate with programmed death-1 (PD-1) inhibitor therapy: A single-center retrospective analysis. 2017 ·Journal of Clinical Oncology ·Mark Yarchoan, Adam Diehl, Burles A. Johnson, Blake Scott, Alexander C. Hopkins, Nilofer S. Azad, Elizabeth M. Jaffee, Stuart A. Grossman	4
12	Relationship of lymphocyte and eosinophil counts and immune-related adverse events in recipients of programmed death-1 (PD-1) inhibitor therapy: A single-center retrospective analysis. 2017 ·Journal of Clinical Oncology ·Adam Diehl, Mark Yarchoan, Ting Yang, Blake Scott, Burles A. Johnson, Alexander C. Hopkins, Nilofer S. Azad, Elizabeth M. Jaffee, Stuart A. Grossman	2
13	Evaluating the Accuracy of Sampling Strategies for Estimation of Compliance Rate for Ventilator-Associated Pneumonia Process Measures 2016 ·Infection Control and Hospital Epidemiology ·Adam Diehl, Ting Yang, Kathleen Speck, James B Battles, Sara E. Cosgrove, Sean M. Berenholtz, Michael Klompas	1
14	An atypical 0.73 MB microduplication of 22q11.21 and a novel SALL4 missense mutation associated with thumb agenesis and radioulnar synostosis 2015 ·American Journal of Medical Genetics Part A ·Adam Diehl, Weiyi Mu, Denise Batista, Meral Gunay‐Aygun	8
15	The Notch Pathway Inhibits TGFβ Signaling in Breast Cancer through HEYL-Mediated Crosstalk 2014 ·Cancer Research ·Liangfeng Han, Adam Diehl, Nguyen K. Nguyen, Preethi Korangath, Wei Wen Teo, Soonweng Cho, Scott L. Kominsky, David L. Huso, Lionel Feigenbaum, Alan Rein, Pedram Argani, Göran Landberg, Manfred Gessler, Saraswati Sukumar	27
16	Horizontal integration of OMIM across the medical school preclinical curriculum for early reinforcement of clinical genetics principles 2014 ·Genetics in Medicine ·Adam Diehl, (unknown), Ada Hamosh, Joann Bodurtha	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact